Clinuvel – FY21 Earnings

Clinuvel Pharmaceuticals is under Algo Engine buy conditions. Company revenues increased 47% in FY21, helping to boost profits by nearly two-thirds to $24.7 million. The revenues were powered by strong patient demand in Europe and the US.  

You’re not a member!  Trial today

Ready to elevate your investing?

Join Investor Signals today and start your journey to better, more disciplined returns.